《半日总结》恒指升57点 国指倒跌 阿里险守200元
中国新型冠状病毒疫情持续扩散，美国对中国发出旅游警示，港股在农历新年假期後复市累跌千五点後反弹乏力。恒指高开308点後，早段曾升369点一度高见26,818点，其後升幅曾显着收窄至24点，半日收市升57点或0.2%，报26,507点；国指倒跌不足1点或不足0.1%，收10,324点。大市半日成交总额527.1亿元，沪、深港通南下交易因内地股市休市暂停。
阿里巴巴(09988.HK)跌0.9%险守200元，腾讯(00700.HK)升0.3%报376.2元，美团(03690.HK)及小米(01810.HK)各升2.9%及1.2%。汇控(00005.HK)升0.5%报57元，友邦(01299.HK)升0.4%，港交所(00388.HK)升1.2%。
中移动(00941.HK)及联通(00762.HK)各升0.8%及1.1%。四大内银方面，工行(01398.HK)跌0.4%，中行(03988.HK)及农行(01288.HK)各升0.3%。内险股中国平安(02318.HK)跌0.9%失守90元，国寿(02628.HK)跌0.1%。
个别通讯设备及晶片股反弹，京信通信(02342.HK)升2.9%，中芯(00981.HK)及华虹半导体(01347.HK)各升2.4%及2.6%。科网股方面，金山软件(03888.HK)及擎天软件(01297.HK)各升4.7%及2.8%，网龙(00777.HK)及阅文(00772.HK)各升2.1%及2.5%。
个别内需股见反弹，汽车股华晨(01114.HK)升2.2%，饮品股维他奶(00345.HK)及体育用品股361度(01361.HK)各升逾3%，内地餐饮股呷哺呷哺(00520.HK)及海底捞(06862.HK)各升2.9%，家电股海尔电器(01169.HK)升2.1%。
主要医药股个别发展，国药(01099.HK)跌2.3%，华润医药(03320.HK)跌3%。白云山(00874.HK)及绿叶制药(02186.HK)各升3.2%及1.9%。中小型医疗股续现炒作，中国医疗(08225.HK)急升41%，半日成交近9.4亿元。中国生命(08296.HK)及先锋医药(01345.HK)各升105%及65%，金威医疗(08143.HK)、莲和医疗(00928.HK)及保集健康(01246.HK)各升33%至39%，大健康国际(02211.HK)、精优药业(00858.HK)及天大药业(00455.HK)则回吐21%至28%。
濠赌股，新濠国际(00200.HK)及美高梅中国(02282.HK)各反弹2.9%及2.2%。电力股方面，中广核新能源(01811.HK)升7.3%，华电国际(01071.HK)及龙源电力(00916.HK)各跌3.4%及3.7%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
